Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.010 AlteredExpression disease BEFREE Here, we demonstrated that FK228 and apicidin exhibited strong resistance in doxorubicin-resistant clones of OS and EFTs expressing P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) and that P-gp and MRP1 might play a crucial role in the resistance mechanism to FK228 and apicidin. 16049968 2006
Entrez Id: 4363
Gene Symbol: ABCC1
ABCC1
0.010 AlteredExpression disease BEFREE Here, we demonstrated that FK228 and apicidin exhibited strong resistance in doxorubicin-resistant clones of OS and EFTs expressing P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) and that P-gp and MRP1 might play a crucial role in the resistance mechanism to FK228 and apicidin. 16049968 2006
Entrez Id: 238
Gene Symbol: ALK
ALK
0.010 Biomarker disease BEFREE The ALK rearrangement may represent the molecular definition of a subgroup of mesenchymal tumors, not always with complete morphological features of IMT, similar to the model of EWS rearrangement in the Ewing sarcoma family of tumors. 11284039 2001
Entrez Id: 427
Gene Symbol: ASAH1
ASAH1
0.010 AlteredExpression disease BEFREE We determined the following: (a) 4-HPR cytotoxicity against 12 ESFT cell lines in vitro; (b) whether 4-HPR increased ceramide species (saturated and desaturated ceramides); (c) whether physiological hypoxia (2% O(2)) affected cytotoxicity, mitochondrial membrane potential (DeltaPsi(m)) change, or ceramide species or reactive oxygen species levels; (d) whether cytotoxicity was enhanced by l-threo-dihydrosphingosine (safingol); (e) whether physiological hypoxia increased acid ceramidase (AC) expression; and (f) the effect of the AC inhibitor N-oleoyl-ethanolamine (NOE) on cytotoxicity and ceramide species. 15289350 2004
Entrez Id: 27087
Gene Symbol: B3GAT1
B3GAT1
0.010 Biomarker disease BEFREE We investigated 44 EFT in terms of a possible correlation between the type of EWS chimeric transcripts and reactivity with the following NgM: polyclonal and monoclonal neuron-specific enolase (NSE), S-100, chromogranin A, synaptophysin, Leu-7, glial fibrillary acid protein, and neurofilament. 10492040 1999
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.010 Biomarker disease BEFREE The Ewing Family of Tumors Relies on BCL-2 and BCL-X<sub>L</sub> to Escape PARP Inhibitor Toxicity. 30348635 2019
Entrez Id: 54880
Gene Symbol: BCOR
BCOR
0.010 GeneticVariation disease BEFREE The aim of the present study was to investigate the IHC expression of NKX2.2, ETV4 and BCOR in a large series of genetically confirmed ESFT. 28864350 2017
Entrez Id: 648
Gene Symbol: BMI1
BMI1
0.010 Biomarker disease BEFREE Together, these data support a pivotal role for BMI-1 ESFT pathogenesis and suggest that its oncogenic function in these tumors is in part mediated through modulation of adhesion pathways. 18701473 2008
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.010 GeneticVariation disease BEFREE We additionally note an increased prevalence of the BRCA2 K3326X polymorphism in EFT patient samples (7.3%) compared to population data (OR 7.1, p = 0.006). 25010205 2014
Entrez Id: 400566
Gene Symbol: C17orf97
C17orf97
0.010 Biomarker disease BEFREE CK20 and neurofilament staining was undertaken to investigate whether some of these neoplasms might exhibit a Merkel cell immunophenotype and CD99 staining to assess whether there is immunohistochemical overlap with neoplasms in the Ewing family of tumors (EFT). 20182342 2010
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 AlteredExpression disease BEFREE Doxorubicin increased caspase-3 activity in two ESFT cell lines, TC-32 and TC-71. 10582694 1999
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.020 AlteredExpression disease BEFREE Using quantitative expression analysis in 16 ESFT and seven alveolar rhabdomyosarcomas (ARMS), we were able to validate the four genes previously described as direct targets of the EWSR1-FLI1 oncoprotein, showing overexpression of CAV1 and NR0B1 and underexpression of IGFBP3 and TGFBR2 in ESFT as compared to ARMS. 23185447 2012
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.020 Biomarker disease BEFREE To determine the effect of CAV1 on the migratory and invasive capabilities of ESFT cells, we knocked down CAV1 expression in TC252 and A673 cells by stably transfecting a previously validated shRNA construct. 21106507 2010
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.010 Biomarker disease BEFREE We investigated the status and expression of p16, p15, CCND1, CDK4 and RB genes in the Ewing family of tumors. 9393981 1997
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.010 AlteredExpression disease BEFREE PD-L1 expression was present in 19% of ESFT, while PD-1 was expressed in 26%. 29445891 2018
Entrez Id: 947
Gene Symbol: CD34
CD34
0.010 Biomarker disease BEFREE PBSC harvests from patients with Ewing family of tumors (EFT) were analyzed for contaminating tumor cells prior and after CD34+ selection using reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry (FC) analyzes. 17369866 2007
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 Biomarker disease BEFREE Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family. 10492040 1999
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 GeneticVariation disease BEFREE Pathologic studies revealed an Ewing sarcoma/peripheral primitive neuroectodermal tumor (EWS/pPNET) with typical features including periodic acid Schiff positive diastase sensitive cytoplasmic substance; strong membranous pattern of immunoreactivity for CD99, and a reciprocal translocation of t(11;22)(q24;q12) that was demonstrated by fluorescent in situ hybridization (FISH). 16196395 2005
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 Biomarker disease BEFREE Establishing histological diagnosis can be difficult; CD99 and FLI1 immunohistochemical staining has improved diagnosis, but these markers are not specific for EFTs. 19411158 2009
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 AlteredExpression disease BEFREE CD99 expression is identified in nearly all ESFT and constitutes a useful positive marker when used as part of a panel of immunostains that can help rule out other differential diagnostic considerations. 16096383 2005
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 AlteredExpression disease BEFREE Our results suggest that in ESFT, high CD99 expression levels contribute to the malignant properties of ESFT by promoting growth and migration of tumor cells and identify KCMF1 as a potential metastasis suppressor gene downregulated by high constitutive CD99 expression in ESFT. 16314831 2006
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 AlteredExpression disease BEFREE The Ewing sarcoma family of tumors (ESFT) is defined by cell surface expression of CD99 and a translocation involving EWS and an ETS partner. 23760780 2013
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 Biomarker disease BEFREE By analogy to heterologous cellular systems, it is possible to postulate an important functional role for CD99(MIC2) as it contributes to the malignant phenotype of EFT. 10416880 1999
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 AlteredExpression disease BEFREE CD99 expression was detected in 10/11 (90%) ESFT cases and 2/7 cPNET cases. 21267687 2011
Entrez Id: 4267
Gene Symbol: CD99
CD99
0.100 Biomarker disease BEFREE CK20 and neurofilament staining was undertaken to investigate whether some of these neoplasms might exhibit a Merkel cell immunophenotype and CD99 staining to assess whether there is immunohistochemical overlap with neoplasms in the Ewing family of tumors (EFT). 20182342 2010